Speaking at the inaugural session of 15th BioAsia Summit, Rao, popularly known as KTR, said the state has further strengthened its leadership position in life sciences innovation and manufacturing hubs by contributing more than 35 per cent to the national pharmaceutical production of the country.
He said Telangana has become a vaccine hub of the country and the world by producing about 33 per cent of global vaccines dosages and significantly contributing to elimination of global pain and disease.
The Genome Valley Cluster here is among the largest life sciences clusters in Asia and the government will continue to support the cluster to strengthen its dominant position, he said.
From humble beginnings in the year 1999, the cluster has grown tremendously to become home to more than 200 companies with approximately 10,000 scientific and technical workforces today, with global majors like Novartis, GSK, Sanofi, Ferring Pharma, Chemo, DuPont, Ashland and US Pharmacopeia among others, the minister added.